The purpose of ST Detect study is to evaluate whether naturally occurring spontaneous coronary events and exercise induced cardiac ischemia, give rise to detectable changes on intracardiac electrogram (EGM) signals in patients that are indicated for an Implantable Cardioverter Defibrillator (ICD) who have coronary artery disease.
Study Type
OBSERVATIONAL
Enrollment
175
Subjects implanted with an ICD.
Unnamed facility
Anchorage, Alaska, United States
Unnamed facility
Brandon, Florida, United States
Number of Participants With ST Segment Changes During Myocardial Infarction
The primary objective of the study was to observe if there are any detectable ST segment changes on an electrogram (EGM) signal from an implanted cardiac defibrillator (ICD) during myocardial infarctions among study participants.
Time frame: Implant to 2 years
Occurrence of Spontaneous Coronary Event
During the study, spontaneous coronary ischemic events were categorized as STEMI, Non-ST elevated myocardial infarction (NSTEMI), or Unstable Angina. This objective was to provide estimates of rates per patient year for the study population. Rates are presented as: Average number of events per patient year (95% Confidence Interval)
Time frame: Implant to 2 years
ST Segment Changes Measured by an ICD in Subjects Who Test Positive for Ischemia During an Exercise Stress Test
Patients underwent an exercise stress test at their one month study visit. This objective was to summarize the magnitude of the hearts electrical activity signal measured by the implanted ICD during a positive exercise stress test for ischemia.
Time frame: One-month follow-up visit
Number of Years of Stored Data in a Database of the Hearts Electrical Activity in This Specific Patient Population to be Used for Future Research.
The device in this study included an additional capacity to collect and store information about the hearts electrical activity specific to ischemic heart disease. This additional capacity of the device is not currently available in market release ICDs. There is no measure to this objective, other than reporting the number of follow-up years of data accrued, which can be used by Medtronic for additional research.
Time frame: Implant to 2 years
Participants That Consented to Wear a Holter Monitor for a Period of 24 Hours to Collect Heart Sounds Data.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Orlando, Florida, United States
Unnamed facility
Davenport, Iowa, United States
Unnamed facility
Boston, Massachusetts, United States
Unnamed facility
Minneapolis, Minnesota, United States
Unnamed facility
Kansas City, Missouri, United States
Unnamed facility
Mineola, New York, United States
Unnamed facility
Stony Brook, New York, United States
Unnamed facility
Gastonia, North Carolina, United States
...and 15 more locations
When study subjects completed their six-month follow-up visit, they were asked if they would consent to wear a Holter monitor for a period of 24 hours to collect Heart Sounds data. The study subject would have to return to the center the following day to return the Holter monitor and have their ICD EGM vectors reprogrammed.
Time frame: Six-month follow-up visit